Precision will be at this year’s Advanced Therapies Week, January 16 – 19, in Miami, FL. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for advanced therapies.

Speaking Engagements
Detailed descriptions for each speaking engagement are included below. 

  • Precision will chair the opening plenary session on January 17, 2024, 9:00 – 10:30 am.
  • Precision will chair panel discussion ‘Non-Viral Solutions for Gene Therapy’ on January 19, 2024, 10:00 – 11:00 am.
  • Project Farma will sponsor the ‘Yacht Party – Under The Stars’ on January 17, 2024, 7:30 – 9:00 pm.
  • Precision will host the opening remarks and present the Cell Therapy Biotech Innovation Award at the Advanced Therapies Awards Ceremony on January 18, 2024.

Connect with our Advanced Therapy experts

  • Visit us through any of the numerous networking opportunities at Advanced Therapies Week
  • Be sure to attend the Project Farma sponsored ‘Yacht Party – Under The Stars’ on January 17, 2024, 7:00 – 9:30 pm
  • Join us for the Advanced Therapies Awards Ceremony on January 18, 2024, 7:00 pm – 12:00 am
  • Schedule an in-person or virtual meeting with our team

You can register for Advanced Therapies Week below:


Opening Plenary Session
Tuesday| January 17, 2024, 9:00 – 10:30 AM
Location: Theatre 3 & 4

  • 9am Chair Introduction
    • Chad Salisbury, Senior Vice President, Project Farma
  • 9.05am Presentation Title: Top 10 Events of 2023 for Cell and Gene Therapies
    • Susan Nicholas, Senior Consultant, Cell and Gene Therapy, Planet Innovation
  • 9.15am Cryport Fireside Chat
    • Chad Salisbury, Senior Vice President, Precision for Medicine
    • Jerrel W. Shelton, President and Chief Executive Officer, Cryoport Inc
  • 9:25am “Special Announcement”
  • 9:35am Presentation Title: Regulatory Updates for Cell and Gene Therapy
    • Celia Witten, Deputy Director, CBER, FDA
  • 9:50am Women in Advanced Therapies: The Power of Collaboration & Community at Scale
    • Lynn Fischer, Founder and Board Member, Title 21
  • 10.05am Panel Discussion
    • Joined by Lore Gruenbaum, Vice President, Therapy Acceleration Program, The Leukemia & Lymphoma Society

‘Non-Viral Solutions for Gene Therapy’ Session
Friday| January 19, 2024, 10:00 – 11:00 AM
Location: Theatre 2

  • Chair Introduction
    • Adam Pfieffer, Vice President of Strategy, Project Farma
  • 10am Presentation
    • Brent Warner, President, Gene Therapy, Poseida Therapeutics
  • 10.15am Presentation: How to retain superior cell health and function following multiple gene-modifications for a cell therapy modalities.
    • Lisa O’Flynn, Sr. Director, Process and Analytical Development, Avectas
  • 10.30am Presentation
    • Paolo Martini, Chief Scientific Officer, International Therapeutics Research Centers, Moderna
  • 10.45am Presentation Title: Non-Viral Manufacturing of Gene Modified Therapies Using TcBuster™
    • David Hermanson, Director of Applications, Bio-Techne